The Oklahoma Medical Research Foundation announced today that Fletcher B. Taylor, Jr., M.D., who has spent more than two decades as a scientist at OMRF, has endowed a chair at the foundation. Taylor’s gift will establish the Alvin Chang Chair in Cardiovascular Biology. The chair is named in honor of Taylor’s longtime senior research assistant, […]
scientist-news
Oklahoma Researchers Show Autoantibodies Occur before Lupus in New England Journal of Medicine Study
In a study published tomorrow in The New England Journal of Medicine, scientists report that in patients suffering from systemic lupus erythematosus (commonly known as lupus), autoantibodies – proteins that the body mistakenly unleashes against its own tissue – are typically present years before patients are diagnosed with the disease. This research by scientists at […]
OMRF Receives $10 Million Grant
The Oklahoma Medical Research Foundation announced today that it has received a $10 million grant from the National Institutes of Health. “This is yet another important step in the emergence of Oklahoma as a center of biomedical excellence,” said OMRF President Dr. J. Donald Capra. “Five years ago, this state had never seen a $10 […]
Gorbsky Joins OMRF
The Oklahoma Medical Research Foundation announced today that Gary Gorbsky, Ph.D., has joined OMRF as head of the molecular and cell biology research program. With this addition, OMRF now counts forty-five principal scientists, its highest tally ever. Gorbsky comes to OMRF from the University of Oklahoma Health Sciences Center, where he was a professor and […]
OMRF Scientist’s Work Chosen for Cover of Leading Journal
An article by Oklahoma Medical Research Foundation scientist Paul W. Kincade, Ph.D., has been selected to appear on the cover of the September 17 issue of Immunity, the leading journal in the field of immunology. Kincade’s article looks at the development of immune cells from the time when they first appear in embryos and compares […]
OMRF and Lilly announce collaboration
The Oklahoma Medical Research Foundation (OMRF) and Eli Lilly and Company (NYSE:LLY) are pleased to announce that they have resolved a lawsuit pending between them in federal court in Oklahoma City involving Lilly’s life saving drug, Xigris®. The terms of the settlement are confidential but it will enable OMRF and Lilly to continue to collaborate […]
